false

Leukemia Program

The Leukemia Program at Mass General Brigham offers advanced diagnostic tests, innovative treatment, and compassionate care, provided by world-recognized leukemia specialists.
primary
phone
855-776-4224

Call the Mass General Brigham Cancer Institute at 855-776-4224

8557764224

Internationally recognized leukemia care

Bone marrow cancers and acute leukemias occur when the bone marrow makes too many or malignant, abnormal blood cells. The disease can be fast or slow-growing and affect all age groups, requiring specialized care for each patient’s unique needs.

The Mass General Brigham Cancer Institute is internationally recognized for its expertise in diagnosing and managing all types of bone marrow cancer. We offer effective and innovative therapeutic options, including targeted agents, novel therapies, bone marrow transplants, and other treatments to help you return to the life that matters most to you.

center
tertiary
internal-arrow
Part of the Cancer Institute
/content/unified-xwalk/en/services/cancer

Our approach to leukemia care

Our experts work as a team to provide you with the latest treatments and compassionate support. We coordinate every aspect of your care.
Deep expertise in leukemia diagnosis and staging

Your care team includes hematopathologists who are known around the world for their expertise in diagnosing all types of leukemia. We use the latest diagnostic tools, including:

  • Advanced microscopy
  • Chromosomal microarray analysis
  • Flow cytometry
  • Fluorescence in situ hybridization (FISH)
  • Genome mapping
  • Karyotyping
  • Histochemical analysis
  • Rapid molecular and genetic testing
Comprehensive medication treatments for leukemia

Our team features blood cancer doctors who focus on specific types of leukemias, ensuring you receive the most effective care plan. You have access to all medications used to treat acute leukemia and other bone marrow cancers, including:

  • Chemotherapy
  • Targeted therapies for subtypes of disease
  • Immunotherapy, including CAR T-cell therapy
Innovative bone marrow transplant options

For some people with leukemia, a bone marrow transplant may be recommended. Through our Bone Marrow Transplant Program, we provide advanced transplant care and evidence-based therapies to help prevent and manage complications that can occur after transplant, including graft-versus-host disease (GVHD).

Transplants we offer for leukemia include:

  • Allogeneic transplant with a matched, related donor
  • Allogeneic transplant with a mismatched or unrelated donor
  • Umbilical cord blood transfusions

Cancer clinical trials and research

Our research is shaping the future of cancer care. We offer access to clinical trials and emerging therapies, including treatments that may not yet be widely available. Eligibility depends on a person’s diagnosis, treatment history, and more. Explore our research and clinical trials or talk with your care team to learn about available options.
A medical professional speaks with a patient seated in a hospital chair.
tertiary
external
Explore our cancer research

Learn how cancer research informs patient care

https://research.massgeneralbrigham.org/en/institutes-centers/cancer-institute-research
tertiary
external
Search clinical trials
https://research.massgeneralbrigham.org/en/institutes-centers/cancer-institute-research/cancer-clinical-trials

Patient resources and support

We offer a range of resources to support patients and caregivers before, during, and after cancer treatment. These services address physical, emotional, and practical needs and are available alongside your medical care.
tertiary
internal-arrow
View all patient resources
/content/unified-xwalk/en/services/cancer/resources

Contact the Cancer Institute

Call us to speak with a team member who can help you understand your options and guide you to the care that is right for you. With locations throughout New England and support for patients traveling from outside the United States, we make it easier to access coordinated, expert care.
primary
phone
855-776-4224

Call the Mass General Brigham Cancer Institute at 855-776-4224

8557764224
secondary
internal
International Patient Services

Contact International Patient Services

/content/unified-xwalk/en/patients-visitors/international/for-patients/contact